| Recent advances in the management of thyroid cancer and type 2 diabetes: highlights from the Annual Conference of the Society for Endocrinology (BES), March 15-18, 2010, Manchester, UK. | |
| | |
MedLine Citation:
|
PMID: 20517537 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The Society for Endocrinology (BES) held its Annual Conference in Manchester, U.K., on March 15-18, 2010. The meeting was devoted to different areas of endocrinology, such as thyroid diseases, abnormalities in adrenal function, neuroendocrine disorders, bone and parathyroid disorders, diabetes, gonadal abnormalities, growth and development, diseases of pituitary and molecular endocrinology. This report focuses on recent developments in thyroid carcinogenesis, where the potential for novel interventions may exist, and new therapeutic possibilities and advances in the management of diabetes and its complications. |
| | |
Authors:
|
P Bandyopadhyay |
Related Documents
:
|
21083457 - Hemophilia: basic and translational science. 20221327 - American society of hematology, 51st annual meeting and exposition. 20582867 - American society of gene & cell therapy--13th annual meeting. 21590407 - Ethical consideration. 9352767 - Assumptions and practice in clinical medical ethics. |
Publication Detail:
|
Type: Congresses |
Journal Detail:
|
Title: Drugs of today (Barcelona, Spain : 1998) Volume: 46 ISSN: 1699-3993 ISO Abbreviation: Drugs Today Publication Date: 2010 May |
Date Detail:
|
Created Date: 2010-06-02 Completed Date: 2010-08-19 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101160518 Medline TA: Drugs Today (Barc) Country: Spain |
Other Details:
|
Languages: eng Pagination: 361-7 Citation Subset: IM |
Copyright Information:
|
Copyright (c) 2010 Prous Science, S.A.U. or its licensors. All rights reserved. |
Affiliation:
|
Sandwell and West Birmingham Hospitals NHS Trust, Lyndon, West Bromwich, West Midlands, UK. prabirbanerjee@yahoo.co.uk |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Diabetes Mellitus, Type 2 / complications, drug therapy*, physiopathology Drug Delivery Systems Humans Hypoglycemic Agents / adverse effects, pharmacology, therapeutic use* Thyroid Neoplasms / physiopathology, therapy* |
| Chemical | |
Reg. No./Substance:
|
0/Hypoglycemic Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Vitamine D analogue-based therapies for psoriasis.
Next Document: A diverse family of Type III polyketide synthases in Eucalyptus species.